tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Opthea Announces Annual General Meeting Date and Director Nomination Deadline
Company AnnouncementsOpthea Announces Annual General Meeting Date and Director Nomination Deadline
3d ago
Opthea Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Opthea Releases 2025 Corporate Governance Statement
4d ago
Opthea’s Bold Strategy in Pharmaceutical Innovation
PremiumCompany Announcements
Opthea’s Bold Strategy in Pharmaceutical Innovation
4d ago
S&P/ASX Indices Rebalance Announced for September 2025
PremiumCompany Announcements
S&P/ASX Indices Rebalance Announced for September 2025
14d ago
Opthea Limited Provides Corporate Update in Investor Presentation
PremiumCompany Announcements
Opthea Limited Provides Corporate Update in Investor Presentation
30d ago
Opthea Limited Announces Quotation of New Securities on ASX
PremiumCompany AnnouncementsOpthea Limited Announces Quotation of New Securities on ASX
1M ago
Opthea Secures Solvency with Successful DFA Settlement
Premium
Company Announcements
Opthea Secures Solvency with Successful DFA Settlement
1M ago
Opthea Limited Relocates Registered Office to Melbourne
Premium
Company Announcements
Opthea Limited Relocates Registered Office to Melbourne
3M ago
Opthea Announces Director Change: Quinton Oswald Steps Down
PremiumCompany Announcements
Opthea Announces Director Change: Quinton Oswald Steps Down
4M ago
Opthea Announces Director Change and Securities Update
PremiumCompany Announcements
Opthea Announces Director Change and Securities Update
4M ago
Opthea Announces Director Departure and Impact on Strategic Direction
PremiumCompany Announcements
Opthea Announces Director Departure and Impact on Strategic Direction
4M ago
Opthea Faces Leadership Changes Amidst Clinical Trial Setbacks
PremiumCompany Announcements
Opthea Faces Leadership Changes Amidst Clinical Trial Setbacks
4M ago
JPMorgan Ceases Substantial Holding in Opthea
PremiumCompany AnnouncementsJPMorgan Ceases Substantial Holding in Opthea
4M ago
Opthea Halts Wet AMD Trials and Cuts Workforce Amid Financial Uncertainty
Premium
Company Announcements
Opthea Halts Wet AMD Trials and Cuts Workforce Amid Financial Uncertainty
5M ago
Opthea Announces Major Workforce Reduction Following Trial Setbacks
Premium
Company Announcements
Opthea Announces Major Workforce Reduction Following Trial Setbacks
5M ago
Opthea terminates COAST trial, announces ShORe trial misses endpoint
PremiumThe Fly
Opthea terminates COAST trial, announces ShORe trial misses endpoint
6M ago
OPT
Opthea Limited’s Securities Suspended Due to Financial Concerns
PremiumCompany Announcements
Opthea Limited’s Securities Suspended Due to Financial Concerns
6M ago
Opthea Halts Wet AMD Trials Following Unsuccessful Phase 3 Results
PremiumCompany Announcements
Opthea Halts Wet AMD Trials Following Unsuccessful Phase 3 Results
6M ago
JPMorgan Chase Acquires Substantial Stake in Opthea Limited
PremiumCompany Announcements
JPMorgan Chase Acquires Substantial Stake in Opthea Limited
6M ago
Opthea downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyOpthea downgraded to Perform from Outperform at Oppenheimer
6M ago
OPT
Opthea downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Opthea downgraded to Market Perform from Outperform at Leerink
6M ago
OPT
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
Premium
The Fly
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
6M ago
OPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >